May 7, 2024
James Helzberg
Share
Article Link: https://pubmed.ncbi.nlm.nih.gov/36626622/
What regimens are most effective for induction and maintenance therapy for patients with autoimmune hepatitis?
April 1, 2022
Can seladelpar serve as second-line treatment for PBC patients with inadequate UDCA therapy?
October 27, 2025
HepMadness
October 15, 2025
